Podcast: Here’s the case for optimism even as COVID infection rates soar

Credit: Jonathan Wiggs/Boston Globe
Credit: Jonathan Wiggs/Boston Globe

On average, the U.S. is tallying nearly 500,000 new COVID cases a day. [January 3], the U.S. hit yet another record high for infections – 1,082,549. So it is something of an act of courage to find glimmers of hope in those numbers, but our next guest says he wants to try.

Dr. Bob Wachter is chair of the Department of Medicine at the University of California, San Francisco.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.
[Wachter:] I think the likeliest outcome for February and March is that we’ll be in pretty good shape. This virus being so transmissible but now, as we understand it, being milder than the prior variants could turn out to be very good news after a very awful January.

But very importantly, for the people that chose not to be vaccinated – I think a very terrible choice – but who made that choice, there’s a pretty good chance they’re going to get a case of omicron, which will give them some immunity.

And it’s those two things combined – the fact that the average case is going to be milder and more and more people are going to be immune to this virus – that gets us out of this pickle, I think, in February.

This is an excerpt. Read the original post here.

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claims? The evidence says mostly the opposite
ChatGPT-Image-May-13-2026-11_56_08-AM
After slashing global health aid by $19 Billion, Trump moves to tap $2.1 billion more—to cover shutdown costs
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
png-pill-omega-Supp-fish-oil
Millions take omega-3 fish oil for brain health. New research suggests it may do the opposite.
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Screenshot-2026-02-20-at-10.48.04-AM
Deepfakes raise profound ethical questions in science
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-12-2026-01_41_42-PM
Viewpoint: ‘Measles is a canary in the healthcare coal mine’: Challenging RFK, Jr.’s scare campaign
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
donut-decorated-with-e-food-additives-tablets
RFK, Jr. is targeting chemical food additives. What does science tell us?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.